Europcar, Cofidis and Sojasun get Tour de France wildcard places

Cofidis, Tour de France 2012 presentation

Amaury Sports Organistion (ASO) confirmed on Saturday the 22 teams that will be taking part in the 2013 edition of the Tour de France (June 29-July 21).

French teams Europcar, Cofidis and Sojasun have received wildcard invites to join the 19 UCI WorldTour squads.

There are usually four wildcard teams selected for the Tour, but after Katusha were awarded a late WorldTour, ProTeam licence by the UCI after an appeal to the Court of Arbitration for Sport, the number of squads in the UCI's top tier was upped from 18 to 19.

Unlike Giro d'Italia organiser RCS Sport, ASO has elected to keep the total number of teams in the Tour at 22 - and therefore three wildcard teams were chosen. Next month's Giro will feature 23 teams.

Each Tour de France team will field nine riders.

Tour de France 2013 teams

Ag2r La Mondiale (Fra)

Argos-Shimano (Ned)

Astana (Kaz)

Blanco (Ned)

BMC Racing (USA)

Cannondale (Ita)

Cofidis (Fra)

Europcar (Fra)

Euskaltel-Euskadi (Spa)

FDJ (Fra)

Garmin-Sharp (USA)

Katusha (Rus)

Lampre-Merida (Ita)

Lotto-Belisol (Bel)

Movistar (Spa)

Omega Pharma-QuickStep (Bel)

Orica GreenEdge (Aus)

RadioShack-Leopard (Lux)

Saxo-Tinkoff (Den)

Sojasun (Fra)

Sky (GBr)

Vacansoleil-DCM (Ned)

Related links

Cycling Weekly's Tour de France news section

Read Cycling Weekly magazine on the day of release wherever you are in the world with our iPad and iPhone edition - International digital edition, UK digital edition. And if you like us, rate us!

Nigel Wynn
Nigel Wynn

Nigel Wynn worked as associate editor on CyclingWeekly.com, he worked almost single-handedly on the Cycling Weekly website in its early days. His passion for cycling, his writing and his creativity, as well as his hard work and dedication, were the original driving force behind the website’s success. Without him, CyclingWeekly.com would certainly not exist on the size and scale that it enjoys today. Nigel sadly passed away, following a brave battle with a cancer-related illness, in 2018. He was a highly valued colleague, and more importantly, n exceptional person to work with - his presence is sorely missed.